Clinical Trials Browser

Phase 2 × Urologic Neoplasms × Ado-Trastuzumab Emtansine × Clear all

NCT02675829 2026-03-04

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Phase 2 Active not recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms, Urologic Neoplasms